- 
             Something wrong with this record ?
 
SARS-CoV-2 viral load assessment in lung transplantation
R. Novysedlak, J. Vachtenheim, I. Stříž, O. Viklický, R. Lischke, Z. Strizova
Language English Country Czech Republic
Document type Case Reports, Journal Article
 NLK 
   
      Directory of Open Access Journals
   
    from 1991
   
      Free Medical Journals
   
    from 1998
   
      PubMed Central
   
    from 2020
   
      ProQuest Central
   
    from 2005-01-01
   
      Medline Complete (EBSCOhost)
   
    from 2006-01-01
   
      Nursing & Allied Health Database (ProQuest)
   
    from 2005-01-01
   
      Health & Medicine (ProQuest)
   
    from 2005-01-01
   
      ROAD: Directory of Open Access Scholarly Resources
   
    from 1998
    
- MeSH
- Bronchoalveolar Lavage Fluid virology MeSH
- COVID-19 diagnosis virology MeSH
- Tissue Donors * MeSH
- Adult MeSH
- Risk Assessment MeSH
- Middle Aged MeSH
- Humans MeSH
- Lung surgery virology MeSH
- Predictive Value of Tests MeSH
- Risk Factors MeSH
- SARS-CoV-2 isolation & purification MeSH
- COVID-19 Testing MeSH
- Lung Transplantation * adverse effects MeSH
- Viral Load MeSH
- Donor Selection * MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
In the era of COVID-19 pandemic, organ transplantation programs were facing serious challenges. The lung transplantation donor pool was extremely limited and SARS-CoV-2 viral load assessment has become a crucial part of selecting an optimal organ donor. Since COVID-19 is a respiratory disease, the viral load is thought to be more important in lung transplantations as compared to other solid organ transplantations. We present two challenging cases of potential lung donors with a questionable COVID-19 status. Based on these cases, we suggest that the cycle threshold (Ct) value should always be requested from the laboratory and the decision whether to proceed with transplantation should be made upon complex evaluation of diverse criteria, including the nasopharyngeal swab and bronchoalveolar lavage PCR results, the Ct value, imaging findings and the medical history. However, as the presence of viral RNA does not ensure infectivity, it is still to be clarified which Ct values are associated with the viral viability. Anti-SARS-CoV-2 IgA antibodies may support the diagnosis and moreover, novel methods, such as quantifying SARS-CoV-2 nucleocapsid antigen in serum may provide important answers in organ transplantations and donor selections.
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22000860
- 003
- CZ-PrNML
- 005
- 20220218080814.0
- 007
- ta
- 008
- 220106s2021 xr a f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.934760 $2 doi
- 035 __
- $a (PubMed)34913356
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Novysedlák, René $7 xx0269260 $u Third Department of Surgery, Prague Lung Transplant Program, First Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
- 245 10
- $a SARS-CoV-2 viral load assessment in lung transplantation / $c R. Novysedlak, J. Vachtenheim, I. Stříž, O. Viklický, R. Lischke, Z. Strizova
- 504 __
- $a Literatura
- 520 9_
- $a In the era of COVID-19 pandemic, organ transplantation programs were facing serious challenges. The lung transplantation donor pool was extremely limited and SARS-CoV-2 viral load assessment has become a crucial part of selecting an optimal organ donor. Since COVID-19 is a respiratory disease, the viral load is thought to be more important in lung transplantations as compared to other solid organ transplantations. We present two challenging cases of potential lung donors with a questionable COVID-19 status. Based on these cases, we suggest that the cycle threshold (Ct) value should always be requested from the laboratory and the decision whether to proceed with transplantation should be made upon complex evaluation of diverse criteria, including the nasopharyngeal swab and bronchoalveolar lavage PCR results, the Ct value, imaging findings and the medical history. However, as the presence of viral RNA does not ensure infectivity, it is still to be clarified which Ct values are associated with the viral viability. Anti-SARS-CoV-2 IgA antibodies may support the diagnosis and moreover, novel methods, such as quantifying SARS-CoV-2 nucleocapsid antigen in serum may provide important answers in organ transplantations and donor selections.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a bronchoalveolární lavážní tekutina $x virologie $7 D001992
- 650 _2
- $a COVID-19 $x diagnóza $x virologie $7 D000086382
- 650 _2
- $a testování na COVID-19 $7 D000086742
- 650 12
- $a výběr dárců $7 D046148
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a plíce $x chirurgie $x virologie $7 D008168
- 650 12
- $a transplantace plic $x škodlivé účinky $7 D016040
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 650 _2
- $a hodnocení rizik $7 D018570
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a SARS-CoV-2 $x izolace a purifikace $7 D000086402
- 650 12
- $a dárci tkání $7 D014019
- 650 _2
- $a virová nálož $7 D019562
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Vachtenheim, Jiří $7 xx0060516 $u Third Department of Surgery, Prague Lung Transplant Program, First Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Stříž, Ilja, $d 1958- $7 jn20000402309 $u Department of Immunology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Viklický, Ondřej, $d 1966- $7 nlk20050170291 $u Department of Nephrology, Transplant Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Lischke, Robert, $d 1966- $7 xx0078729 $u Third Department of Surgery, Prague Lung Transplant Program, First Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Střížová, Zuzana, $d 1991- $7 hka20191025149 $u Department of Immunology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 70, Suppl. 2 (2021), s. S253-S258
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34913356 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y p $z 0
- 990 __
- $a 20220106 $b ABA008
- 991 __
- $a 20220218080806 $b ABA008
- 999 __
- $a ok $b bmc $g 1761107 $s 1152006
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 70 $c S2 $d S253-S258 $e 20211216 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $b NLK118 $a Pubmed-20220106
